Aethlon Medical: (OTCBB: AEMD)
$0.11
0.00 (0.18%)
Volume 117,473
May 17 03:59 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 0.10 - 0.11 |
| 52wk Low - High | 0.06 - 0.15 |
| Previous Close | 0.11 |
| Avg. Volume | 191,055 |
| Industry | MED-HMO |
| Market Cap | 17.99 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.62 |
| PE (Forward) | 0.00 |
| Current Year Est. | -0.03 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
NA |
Zacks Industry Rank
|
30 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | -0.03 |
| Current Quarter Estimate | -0.01 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | NA |
| EPS Last Year | NA |
| Expected Earnings Growth | NA |
Company Description
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| AETHLON MEDICAL | AEMD | 0.11 | |
|
| MOLINA HLTHCR | MOH | 38.04 | |
|
| AETNA INC-NEW | AET | 60.04 | |
|
| CENTENE CORP | CNC | 51.86 | |
|
| HEALTH NET INC | HNT | 31.00 | |
|
| HUMANA INC NEW | HUM | 80.45 | |
|
| TRIPLE-S MGMT-B | GTS | 18.74 | |
|
| WELLPOINT INC | WLP | 77.81 | |
|
| WELLCARE HEALTH | WCG | 54.66 | |
|
| MAGELLAN HLTH | MGLN | 51.70 | |
|
Sector:Medical>> Industry:MED-HMO
COMPARE TICKER vs. Its Peers
Zacks Commentary
WellCare to join Georgia TeleHealth
Mar 07, 2013
Humana Reiterated Neutral
Mar 06, 2013
AEMD: DAPRA Revenue, Operational Progress Continues
Feb 14, 2013
IDE Submitted Seeking Approval of U.S. Feasibility Study
Jan 03, 2013
Compassionate Use Program at Medicity to Commence
Dec 04, 2012
AEMD: Hitting Milestones, Operational Progress
Nov 20, 2012
AEMD: Expanded Use Program Protocol Announced
Oct 03, 2012
AEMD - DARPA Picks Up Year 2 Option
Aug 21, 2012
Financials
| EPS TTM | NA |
| Sales | 1 |
| Net Income | -7 |
| Price/Earnings | NA |
| Price/Book | NA |
| Price/Cash Flow | NA |
| Price/Sales | 14.87 |
News
Biotech Stock Alert; Aethlon Medical (OTC: AEMD) Releases Shareholder Letter - Benzinga
Nov 16, 2011
Aethlon Medical Introduces Novel Therapeutic Device Strategy to Address Breast Cancer - Benzinga
Sep 21, 2011
Q&A with Aethlon Medical CEO, Jim Joyce; The Potential for the Hemopurifier?? Medical Device in Cancer Immunotherapy - Benzinga
Jun 28, 2011
Aethlon Medical to Present at Tomorrow's RedChip Small-Cap Equities Virtual Conference VIII - Comtex
Jun 21, 2011
Aethlon Medical to Present at Tomorrow's RedChip Small-Cap Equities Virtual Conference VIII - Comtex
Jun 21, 2011
Mining and Gold Stocks; Gold Bullion Identifies Strong, New Vein Structure At Castle Silver Mine, Gowganda - Benzinga
Jun 8, 2011
Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16 - Comtex
Jun 7, 2011
Aethlon Medical President Rodney S. Kenley to Present at the 20th International Vicenza Course on Hemodialysis and CKD - Comtex
Jun 2, 2011
Broker Recommendations
| Current ABR | 3.00 |
| ABR (Last Week) | 3.00 |
| # of recs in ABR | 1 |
| Average Target Price | 0.11 |
| Industry Rank by ABR | 30 out of 265 |
| Rank in Industry | 8 out of 12 |
